Global sites see growth in trials, revenue, staffing
But remain wary about expansion, economic recovery
Industry struggles with prospect of trials leaving U.S.
Must grapple with issues of quotas, populations, differences in dosing
Lundbeck aims to become a world leader in psychiatry and neurology, and improve the quality of life of people suffering from disorders in these areas, by developing and providing innovative specialty therapies.